These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1802683)

  • 1. Insulin-stimulated glucose uptake and fasting blood glucose.
    Okamoto M; Okamoto M; Nishimura H; Kosaki A; Kono S; Inoue G; Maeda I; Kubota M; Hayashi T; Kuzuya H
    Endocrinol Jpn; 1991 Aug; 38(4):421-7. PubMed ID: 1802683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
    Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
    Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
    Niskanen L; Sarlund H; Laakso M
    Metabolism; 1995 Aug; 44(8):1099-104. PubMed ID: 7637652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB; Chen YD; Reaven GM
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.
    Baron AD; Laakso M; Brechtel G; Edelman SV
    J Clin Invest; 1991 Apr; 87(4):1186-94. PubMed ID: 2010535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
    Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.